IL130001A0 - Diphenylalkyl-tetrahydropyridines process for their preparation and pharmaceuticals compositions containing them - Google Patents

Diphenylalkyl-tetrahydropyridines process for their preparation and pharmaceuticals compositions containing them

Info

Publication number
IL130001A0
IL130001A0 IL13000197A IL13000197A IL130001A0 IL 130001 A0 IL130001 A0 IL 130001A0 IL 13000197 A IL13000197 A IL 13000197A IL 13000197 A IL13000197 A IL 13000197A IL 130001 A0 IL130001 A0 IL 130001A0
Authority
IL
Israel
Prior art keywords
pct
preparation
compositions containing
tetrahydropyridines
diphenylalkyl
Prior art date
Application number
IL13000197A
Other languages
English (en)
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IL130001A0 publication Critical patent/IL130001A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13000197A 1996-12-13 1997-12-12 Diphenylalkyl-tetrahydropyridines process for their preparation and pharmaceuticals compositions containing them IL130001A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615336A FR2757161B1 (fr) 1996-12-13 1996-12-13 Diphenylalkyl-tetrahydropyridines
PCT/FR1997/002289 WO1998025904A1 (fr) 1996-12-13 1997-12-12 Diphenylalkyl-tetrahydropyridines, procede pour leur preparation et composition pharmaceutique les contenant

Publications (1)

Publication Number Publication Date
IL130001A0 true IL130001A0 (en) 2000-02-29

Family

ID=9498642

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13000197A IL130001A0 (en) 1996-12-13 1997-12-12 Diphenylalkyl-tetrahydropyridines process for their preparation and pharmaceuticals compositions containing them
IL130001A IL130001A (en) 1996-12-13 1999-05-18 Diphenylalkyl-tetrahydropyridine, the process for their preparation and the pharmaceutical preparations containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL130001A IL130001A (en) 1996-12-13 1999-05-18 Diphenylalkyl-tetrahydropyridine, the process for their preparation and the pharmaceutical preparations containing them

Country Status (31)

Country Link
US (1) US6124318A (no)
EP (1) EP0950049B1 (no)
JP (1) JP2001505903A (no)
KR (1) KR100549656B1 (no)
CN (1) CN1144784C (no)
AT (1) ATE207056T1 (no)
AU (1) AU730142B2 (no)
BR (1) BR9713926A (no)
CA (1) CA2274946C (no)
CY (1) CY2282B1 (no)
CZ (1) CZ290242B6 (no)
DE (1) DE69707504T2 (no)
DK (1) DK0950049T3 (no)
EE (1) EE03764B1 (no)
ES (1) ES2167805T3 (no)
FR (1) FR2757161B1 (no)
HK (1) HK1024001A1 (no)
HU (1) HUP0001437A3 (no)
IL (2) IL130001A0 (no)
IS (1) IS2001B (no)
NO (1) NO313282B1 (no)
NZ (1) NZ336032A (no)
PL (1) PL192926B1 (no)
PT (1) PT950049E (no)
RS (1) RS49672B (no)
RU (1) RU2198874C2 (no)
SI (1) SI0950049T1 (no)
SK (1) SK283332B6 (no)
TR (1) TR199901290T2 (no)
UA (1) UA52708C2 (no)
WO (1) WO1998025904A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
WO2001078709A2 (en) * 2000-04-12 2001-10-25 Minerva Biotechnologies Corporation Treatment of neurodegenerative disease
US6699866B2 (en) 2001-04-17 2004-03-02 Sepracor Inc. Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
CA2551946A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galantamine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
BE775611A (fr) * 1970-11-24 1972-03-16 Synthelabo Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
US5266573A (en) * 1989-08-07 1993-11-30 Elf Sanofi Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser

Also Published As

Publication number Publication date
BR9713926A (pt) 2000-03-21
DE69707504T2 (de) 2002-06-27
CN1144784C (zh) 2004-04-07
KR20000069421A (ko) 2000-11-25
CZ211099A3 (cs) 1999-09-15
WO1998025904A1 (fr) 1998-06-18
SK78799A3 (en) 1999-12-10
SI0950049T1 (en) 2002-10-31
EP0950049B1 (fr) 2001-10-17
HUP0001437A3 (en) 2001-12-28
ES2167805T3 (es) 2002-05-16
NO992870L (no) 1999-08-11
FR2757161A1 (fr) 1998-06-19
NO992870D0 (no) 1999-06-11
IS2001B (is) 2005-04-15
EP0950049A1 (fr) 1999-10-20
KR100549656B1 (ko) 2006-02-08
DK0950049T3 (da) 2002-01-28
FR2757161B1 (fr) 1999-03-12
SK283332B6 (sk) 2003-06-03
NZ336032A (en) 2000-12-22
CA2274946A1 (en) 1998-06-18
PT950049E (pt) 2002-03-28
IS5074A (is) 1999-06-10
RS49672B (sr) 2007-11-15
TR199901290T2 (xx) 1999-08-23
DE69707504D1 (de) 2001-11-22
YU26399A (sh) 2000-03-21
NO313282B1 (no) 2002-09-09
CY2282B1 (en) 2003-07-04
EE9900238A (et) 1999-12-15
PL192926B1 (pl) 2006-12-29
CA2274946C (en) 2005-09-20
AU730142B2 (en) 2001-03-01
HK1024001A1 (en) 2000-09-29
PL334073A1 (en) 2000-01-31
UA52708C2 (uk) 2003-01-15
US6124318A (en) 2000-09-26
JP2001505903A (ja) 2001-05-08
IL130001A (en) 2006-04-10
CZ290242B6 (cs) 2002-06-12
HUP0001437A2 (hu) 2000-09-28
AU5489598A (en) 1998-07-03
ATE207056T1 (de) 2001-11-15
CN1240428A (zh) 2000-01-05
RU2198874C2 (ru) 2003-02-20
EE03764B1 (et) 2002-06-17

Similar Documents

Publication Publication Date Title
DK0794949T3 (da) Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler
BR9611618A (pt) Composto processo para sua preparação composição farmacêutica e utilização de um compostos
DE69231445D1 (de) Triazole enthaltende antifungizide mittel
IL130001A0 (en) Diphenylalkyl-tetrahydropyridines process for their preparation and pharmaceuticals compositions containing them
IL110040A (en) Pyridazinone derivatives their preparation and pharmaceutical compositions comprising them
IL106469A (en) Pyridyl- and pyrimidylpiperazine compounds methods for the manufacture of said compounds and pharmaceutical compositions comprising said compounds
IL109398A (en) Benzo(f) quinoxalinedione derivatives processes for the preparation thereof and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed